Opinion
Accepted on 24 Feb 2026
Growth Differentiation Factor 15 (GDF-15) as an emerging biomarker for cardiovascular and kidney diseases, a therapeutic target in cancer and a potential biomarker for Preeclampsia
in Pharmacogenetics and Pharmacogenomics